CDER?s Division of Post-Marketing Evaluation for Quality Assessment

CONTINUE TO SITE

OR WAIT null SECS

Chromatography Simplified: Maximizing the Power of PDA Data via Fully Integrated CDS Spectral Processing Tools Combustion Ion Chromatography: The What, How, Why, & Where Shedding a New Light on Adeno-Associated Virus Characterization Using SEC-MALS New Gas Chromatography Products for 2021–2022 New HPLC, MS, and CDS Products Introduced in 2021–2022: A Brief Review

Chromatography Simplified: Maximizing the Power of PDA Data via Fully Integrated CDS Spectral Processing ToolsCombustion Ion Chromatography: The What, How, Why, & WhereShedding a New Light on Adeno-Associated Virus Characterization Using SEC-MALSNew Gas Chromatography Products for 2021–2022New HPLC, MS, and CDS Products Introduced in 2021–2022: A Brief Review

Topics

View More Liquid Chromatography (LC/HPLC)Gas Chromatography (GC)Sample Preparation Mass Spectrometry Pharmaceutical Analysis Environmental Analysis Food and Beverage Analysis

Liquid Chromatography (LC/HPLC)Gas Chromatography (GC)Sample PreparationMass SpectrometryPharmaceutical AnalysisEnvironmental AnalysisFood and Beverage Analysis

Publications

All Publications LCGC North America LCGC Europe LCGC Asia Pacific LCGC Supplements The Column E-Books The Application Notebook

All PublicationsLCGC North AmericaLCGC EuropeLCGC Asia PacificLCGC SupplementsThe ColumnE-BooksThe Application Notebook

All NewsInterviews

All App Notes Biological, Medical, and Clinical Biopharmaceuticals Cannabis Chiral Environmental Food and Beverage GC GC-MS General Industrial LC LC-MS Medical/Biological Misc Techniques Pharmaceuticals Polymers Sample Prep Size-Exclusion Chromatography (SEC)Supercritical Fluid Chromatography (SFC)

All App NotesBiological, Medical, and ClinicalBiopharmaceuticalsCannabisChiralEnvironmentalFood and BeverageGCGC-MSGeneralIndustrialLCLC-MSMedical/BiologicalMisc TechniquesPharmaceuticalsPolymersSample PrepSize-Exclusion Chromatography (SEC)Supercritical Fluid Chromatography (SFC)

E-Books Webcasts

Resources

Products ChromTube Events Analytically Speaking Podcast Podcasts Podcast Series Sponsored Videos Q&As Sponsored Content Content Engagement Hubs Tips & Tricks Industry Insights

ProductsChromTubeEventsAnalytically Speaking PodcastPodcastsPodcast SeriesSponsored VideosQ&AsSponsored ContentContent Engagement HubsTips & TricksIndustry Insights

Enewsletters Magazine North America Magazine Europe Magazine Asia Pacific The Column

EnewslettersMagazine North AmericaMagazine EuropeMagazine Asia PacificThe Column

CDER?s Division of Post-Marketing Evaluation for Quality Assessment

July 1, 2006

Special Issues

LCGC Supplements, Special Issues-07-01-2006, Volume 0, Issue 0

The new Division of Post Marketing Evaluation in the Office of New Drug Quality Assessment has implemented an improved system for managing the submission and review processes for post approval chemistry, manufacturing, and controls change supplements.